PortfoliosLab logoPortfoliosLab logo
2B70.DE vs. ESIH.DE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

2B70.DE vs. ESIH.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc) (ESIH.DE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, 2B70.DE achieves a 4.53% return, which is significantly higher than ESIH.DE's -2.35% return.


2B70.DE

1D
3.29%
1M
0.58%
YTD
4.53%
6M
4.05%
1Y
39.50%
3Y*
10.00%
5Y*
5.68%
10Y*

ESIH.DE

1D
3.10%
1M
0.16%
YTD
-2.35%
6M
-1.01%
1Y
6.11%
3Y*
2.72%
5Y*
5.74%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

2B70.DE vs. ESIH.DE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
2B70.DE
iShares Nasdaq US Biotechnology UCITS ETF
4.53%18.62%4.60%2.56%-6.29%7.59%5.89%
ESIH.DE
iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc)
-2.35%7.95%4.09%7.63%-4.59%25.93%-0.69%

Correlation

The correlation between 2B70.DE and ESIH.DE is 0.56, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.56

Correlation (3Y)
Calculated over the trailing 3-year period

0.51

Correlation (5Y)
Calculated over the trailing 5-year period

0.53

Correlation (All Time)
Calculated using the full available price history since Nov 23, 2020

0.52

The correlation between 2B70.DE and ESIH.DE has been stable across timeframes, ranging from 0.51 to 0.56 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

2B70.DE vs. ESIH.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

2B70.DE
2B70.DE Risk / Return Rank: 7171
Overall Rank
2B70.DE Sharpe Ratio Rank: 6262
Sharpe Ratio Rank
2B70.DE Sortino Ratio Rank: 6363
Sortino Ratio Rank
2B70.DE Omega Ratio Rank: 5656
Omega Ratio Rank
2B70.DE Calmar Ratio Rank: 9292
Calmar Ratio Rank
2B70.DE Martin Ratio Rank: 8484
Martin Ratio Rank

ESIH.DE
ESIH.DE Risk / Return Rank: 1515
Overall Rank
ESIH.DE Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
ESIH.DE Sortino Ratio Rank: 1515
Sortino Ratio Rank
ESIH.DE Omega Ratio Rank: 1414
Omega Ratio Rank
ESIH.DE Calmar Ratio Rank: 1515
Calmar Ratio Rank
ESIH.DE Martin Ratio Rank: 1414
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

2B70.DE vs. ESIH.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc) (ESIH.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


2B70.DEESIH.DEDifference
Sharpe ratioReturn per unit of total volatility

+1.69

Sortino ratioReturn per unit of downside risk

+2.26

Omega ratioGain probability vs. loss probability

1.34

1.07

+0.27

Calmar ratioReturn relative to maximum drawdown

6.15

0.47

+5.69

Martin ratioReturn relative to average drawdown

17.06

1.05

+16.01

2B70.DE vs. ESIH.DE - Sharpe Ratio Comparison

The current 2B70.DE Sharpe Ratio is 2.04, which is higher than the ESIH.DE Sharpe Ratio of 0.35. The chart below compares the historical Sharpe Ratios of 2B70.DE and ESIH.DE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


2B70.DEESIH.DEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.04

0.35

+1.69

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.28

0.36

-0.08

Sharpe Ratio (All Time)

Calculated using the full available price history

0.36

0.41

-0.05

Drawdowns

2B70.DE vs. ESIH.DE - Drawdown Comparison

The maximum 2B70.DE drawdown since its inception was -30.87%, which is greater than ESIH.DE's maximum drawdown of -26.69%. Use the drawdown chart below to compare losses from any high point for 2B70.DE and ESIH.DE.


Loading charts...

Drawdown Indicators


2B70.DEESIH.DEDifference

Max Drawdown

Largest peak-to-trough decline

-30.87%

-26.69%

-4.18%

Max Drawdown (1Y)

Largest decline over 1 year

-6.33%

-12.82%

+6.49%

Max Drawdown (3Y)

Largest decline over 3 years

-29.34%

-26.69%

-2.65%

Max Drawdown (5Y)

Largest decline over 5 years

-30.87%

-26.69%

-4.18%

Current Drawdown

Current decline from peak

-1.26%

-10.96%

+9.70%

Average Drawdown

Average peak-to-trough decline

-10.01%

-7.24%

-2.77%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.29%

5.75%

-3.46%

Volatility

2B70.DE vs. ESIH.DE - Volatility Comparison

iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) has a higher volatility of 6.65% compared to iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc) (ESIH.DE) at 5.87%. This indicates that 2B70.DE's price experiences larger fluctuations and is considered to be riskier than ESIH.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


2B70.DEESIH.DEDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.65%

5.87%

+0.78%

Volatility (6M)

Calculated over the trailing 6-month period

14.26%

11.96%

+2.30%

Volatility (1Y)

Calculated over the trailing 1-year period

19.09%

17.18%

+1.91%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

20.34%

15.86%

+4.48%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

21.76%

15.61%

+6.15%

2B70.DE vs. ESIH.DE - Expense Ratio Comparison

2B70.DE has a 0.35% expense ratio, which is higher than ESIH.DE's 0.18% expense ratio.


Dividends

2B70.DE vs. ESIH.DE - Dividend Comparison

Neither 2B70.DE nor ESIH.DE has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


2B70.DE and ESIH.DE have a correlation of 0.56, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, ESIH.DE is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.

ESIH.DE is cheaper with a 0.18% expense ratio, compared with 0.35% for 2B70.DE.

2B70.DE tracks Nasdaq Biotechnology, while ESIH.DE tracks MSCI World/Health Care NR USD. Their fees differ too: 0.35% for 2B70.DE and 0.18% for ESIH.DE.

Portfolio Optimizer

Find the right allocation for 2B70.DE and ESIH.DE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer